Anemia, Hemolytic, Congenital Nonspherocytic
"Anemia, Hemolytic, Congenital Nonspherocytic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any one of a group of congenital hemolytic anemias in which there is no abnormal hemoglobin or spherocytosis and in which there is a defect of glycolysis in the erythrocyte. Common causes include deficiencies in GLUCOSE-6-PHOSPHATE ISOMERASE; PYRUVATE KINASE; and GLUCOSE-6-PHOSPHATE DEHYDROGENASE.
MeSH Number(s)
C15.378.071.141.150.100
C16.320.070.100
Concept/Terms
Anemia, Hemolytic, Congenital Nonspherocytic- Anemia, Hemolytic, Congenital Nonspherocytic
- Anemia, Hemolytic Congenital, Nonspherocytic
- Hemolytic Anemia, Congenital Nonspherocytic
- Anemia, Congenital Nonspherocytic Hemolytic
- Congenital Nonspherocytic Hemolytic Anemia
Below are MeSH descriptors whose meaning is more general than "Anemia, Hemolytic, Congenital Nonspherocytic".
- Diseases [C]
- Hemic and Lymphatic Diseases [C15]
- Hematologic Diseases [C15.378]
- Anemia [C15.378.071]
- Anemia, Hemolytic [C15.378.071.141]
- Anemia, Hemolytic, Congenital [C15.378.071.141.150]
- Anemia, Hemolytic, Congenital Nonspherocytic [C15.378.071.141.150.100]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
- Anemia, Hemolytic, Congenital [C16.320.070]
- Anemia, Hemolytic, Congenital Nonspherocytic [C16.320.070.100]
Below are MeSH descriptors whose meaning is more specific than "Anemia, Hemolytic, Congenital Nonspherocytic".
This graph shows the total number of publications written about "Anemia, Hemolytic, Congenital Nonspherocytic" by people in Harvard Catalyst Profiles by year, and whether "Anemia, Hemolytic, Congenital Nonspherocytic" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2018 | 5 | 0 | 5 |
| 2019 | 2 | 0 | 2 |
| 2020 | 7 | 0 | 7 |
| 2021 | 2 | 0 | 2 |
| 2022 | 5 | 2 | 7 |
| 2023 | 2 | 0 | 2 |
Below are the most recent publications written about "Anemia, Hemolytic, Congenital Nonspherocytic" by people in Profiles.
-
The Pyruvate Kinase Deficiency Global Longitudinal (Peak) Registry: rationale and study design. BMJ Open. 2023 Mar 23; 13(3):e063605.
-
Early-onset reduced bone mineral density in patients with pyruvate kinase deficiency. Am J Hematol. 2023 03; 98(3):E57-E60.
-
An evaluation of mitapivat for the treatment of hemolytic anemia in adults with pyruvate kinase deficiency. Expert Rev Hematol. 2022 10; 15(10):875-885.
-
Mitapivat in adult patients with pyruvate kinase deficiency receiving regular transfusions (ACTIVATE-T): a multicentre, open-label, single-arm, phase 3 trial. Lancet Haematol. 2022 Oct; 9(10):e724-e732.
-
Pyruvate kinase deficiency: clinical expression and new therapies. Clin Adv Hematol Oncol. 2022 07; 20(7):422-425.
-
Mitapivat versus Placebo for Pyruvate Kinase Deficiency. Reply. N Engl J Med. 2022 06 30; 386(26):2539.
-
Diagnosis, monitoring, and management of pyruvate kinase deficiency in children. Pediatr Blood Cancer. 2022 08; 69(8):e29696.
-
Mitapivat versus Placebo for Pyruvate Kinase Deficiency. N Engl J Med. 2022 04 14; 386(15):1432-1442.
-
Health-related quality of life and fatigue in children and adults with pyruvate kinase deficiency. Blood Adv. 2022 03 22; 6(6):1844-1853.
-
Pyruvate kinase deficiency in children. Pediatr Blood Cancer. 2021 09; 68(9):e29148.